PRAZOSIN

PRAZOSIN was reported 6237 times

PRAZOSIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANALGESIC DRUG LEVEL ABOVE THERAPEUTIC 32 0.2177
1 SLEEP SEX 9 0.1500
2 CARDIAC AUTONOMIC NEUROPATHY 7 0.1346
3 BLOOD PRESSURE AMBULATORY INCREASED 6 0.1304
4 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 32 0.1236
5 METABOLIC MYOPATHY 5 0.0909
6 POST CHOLECYSTECTOMY SYNDROME 23 0.0813
7 NOREPINEPHRINE INCREASED 10 0.0763
8 ASPARTATE AMINOTRANSFERASE 14 0.0574
9 GRANULOCYTE COUNT INCREASED 22 0.0543
10 CORNEAL REFLEX DECREASED 16 0.0426
11 SUPINE HYPERTENSION 8 0.0423
12 BLOOD IMMUNOGLOBULIN A INCREASED 22 0.0408
13 HEART FAILURE WITH PRESERVED EJECTION FRACTION 11 0.0374
14 PARASOMNIA 25 0.0348
15 CENTRAL NERVOUS SYSTEM LUPUS 7 0.0314
16 GLOMERULAR FILTRATION RATE INCREASED 24 0.0291
17 VITAMIN B12 INCREASED 23 0.0289
18 BODY MASS INDEX ABNORMAL 7 0.0287
19 RENAL PAPILLARY NECROSIS 6 0.0279
20 ELECTRIC SHOCK 23 0.0268
21 GROSS MOTOR DELAY 7 0.0246
22 DACTYLITIS 23 0.0234
23 ANTIPSYCHOTIC DRUG LEVEL DECREASED 11 0.0207
24 RHEUMATOID FACTOR INCREASED 23 0.0206
25 BEZOAR 26 0.0188
26 ABNORMAL SLEEP-RELATED EVENT 24 0.0182
27 ADRENAL NEOPLASM 8 0.0171
28 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 6 0.0156
29 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 12 0.0154
30 ACTIVATION SYNDROME 5 0.0145
31 SYSTOLIC DYSFUNCTION 15 0.0142
32 OCCIPITAL NEURALGIA 8 0.0142
33 BORDERLINE PERSONALITY DISORDER 10 0.0141
34 SLEEP-RELATED EATING DISORDER 13 0.0139
35 POST-TRAUMATIC STRESS DISORDER 91 0.0136
36 JOINT NOISE 26 0.0132
37 PILOERECTION 14 0.0128
38 INTERVERTEBRAL DISCITIS 24 0.0127
39 SEROSITIS 7 0.0127
40 VASOPLEGIA SYNDROME 20 0.0122
41 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 13 0.0118
42 WHITE BLOOD CELLS URINE POSITIVE 22 0.0117
43 C-REACTIVE PROTEIN DECREASED 7 0.0107
44 CARDIAC HYPERTROPHY 11 0.0099
45 ASPARTATE AMINOTRANSFERASE ABNORMAL 15 0.0098
46 SUDDEN CARDIAC DEATH 33 0.0097
47 ANXIETY DISORDER 31 0.0093
48 ATRIOVENTRICULAR BLOCK FIRST DEGREE 40 0.0092
49 MYASTHENIC SYNDROME 7 0.0090
50 COMPULSIVE SEXUAL BEHAVIOUR 7 0.0086
51 PUPILLARY REFLEX IMPAIRED 16 0.0086
52 URINE LEUKOCYTE ESTERASE POSITIVE 6 0.0086
53 AREFLEXIA 22 0.0082
54 TOOTH EROSION 10 0.0082
55 AUTONOMIC NEUROPATHY 8 0.0079
56 PRIAPISM 27 0.0078
57 SECONDARY IMMUNODEFICIENCY 9 0.0074
58 LICHEN SCLEROSUS 5 0.0073
59 MONOCYTE COUNT INCREASED 25 0.0069
60 SUSPECTED SUICIDE 32 0.0068
61 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 8 0.0067
62 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 9 0.0067
63 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 33 0.0064
64 VENTRICULAR HYPOKINESIA 20 0.0062
65 VITAMIN B12 DEFICIENCY 25 0.0062
66 SLEEP PARALYSIS 9 0.0061
67 SUICIDAL BEHAVIOUR 25 0.0060
68 BLOOD PRESSURE SYSTOLIC DECREASED 27 0.0059
69 HYPERTRICHOSIS 11 0.0059
70 DISSOCIATION 45 0.0059
71 THROAT CLEARING 22 0.0059
72 DEMYELINATION 24 0.0059
73 COMPULSIVE SHOPPING 12 0.0058
74 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 19 0.0057
75 BRASH SYNDROME 8 0.0057
76 BONE DEMINERALISATION 6 0.0057
77 ANOGENITAL WARTS 5 0.0056
78 SOMNAMBULISM 36 0.0055
79 IMPAIRED GASTRIC EMPTYING 74 0.0054
80 SUBSTANCE USE 8 0.0051
81 CARDIOGENIC SHOCK 73 0.0051
82 PULSELESS ELECTRICAL ACTIVITY 21 0.0050
83 COMPARTMENT SYNDROME 13 0.0050
84 NEPHROGENIC ANAEMIA 23 0.0050
85 SINUS BRADYCARDIA 47 0.0049
86 COGWHEEL RIGIDITY 5 0.0048
87 SLEEP DEFICIT 10 0.0047
88 PRODUCT ADMINISTRATION INTERRUPTED 37 0.0047
89 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
90 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 15 0.0045
91 SCHIZOAFFECTIVE DISORDER 8 0.0045
92 HYPERLACTACIDAEMIA 12 0.0045
93 HYPERPARATHYROIDISM SECONDARY 11 0.0044
94 AGORAPHOBIA 6 0.0044
95 PRE-EXISTING CONDITION IMPROVED 27 0.0043
96 ASPIRATION 47 0.0043
97 MAST CELL ACTIVATION SYNDROME 6 0.0043
98 LUPUS NEPHRITIS 8 0.0043
99 CATAPLEXY 6 0.0042
100 CHOLECYSTITIS ACUTE 24 0.0042
101 ALCOHOLISM 18 0.0042
102 BLOOD URIC ACID INCREASED 24 0.0042
103 SUBSTANCE USE DISORDER 13 0.0041
104 GASTROINTESTINAL HYPOMOTILITY 9 0.0040
105 DISTRIBUTIVE SHOCK 9 0.0040
106 FOOD INTERACTION 7 0.0040
107 SEROTONIN SYNDROME 73 0.0038
108 COMA SCALE ABNORMAL 11 0.0038
109 DEREALISATION 8 0.0037
110 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
111 GAMBLING DISORDER 10 0.0037
112 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
113 REBOUND ACID HYPERSECRETION 11 0.0036
114 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
115 PARADOXICAL DRUG REACTION 13 0.0035
116 PUPIL FIXED 6 0.0035
117 BRAIN INJURY 34 0.0034
118 ALCOHOL ABUSE 9 0.0034
119 BRAIN HERNIATION 10 0.0033
120 HYPERTENSIVE CRISIS 37 0.0033
121 CLONUS 9 0.0033
122 VITAMIN D DEFICIENCY 32 0.0033
123 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
124 MEAN CELL VOLUME DECREASED 5 0.0032
125 POLYCYSTIC OVARIES 5 0.0032
126 BIPOLAR I DISORDER 7 0.0032
127 NARCOLEPSY 6 0.0032
128 BLOOD PRESSURE DIASTOLIC DECREASED 23 0.0031
129 SPINAL DISORDER 29 0.0031
130 HOMICIDAL IDEATION 12 0.0030
131 LIBIDO INCREASED 6 0.0030
132 STRESS CARDIOMYOPATHY 17 0.0029
133 KIDNEY TRANSPLANT REJECTION 14 0.0029
134 LOW BIRTH WEIGHT BABY 23 0.0029
135 MIOSIS 23 0.0029
136 CARTILAGE INJURY 7 0.0028
137 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
138 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0028
139 BLOOD HIV RNA INCREASED 5 0.0028
140 NEUTROPHIL COUNT INCREASED 28 0.0027
141 PULMONARY CONGESTION 36 0.0027
142 TEMPERATURE INTOLERANCE 28 0.0027
143 INJECTION SITE CELLULITIS 5 0.0027
144 METABOLIC ENCEPHALOPATHY 8 0.0027
145 NIGHTMARE 92 0.0027
146 CRANIOCEREBRAL INJURY 8 0.0026
147 ELECTROCARDIOGRAM QT PROLONGED 95 0.0026
148 ALCOHOL POISONING 7 0.0026
149 HYPOREFLEXIA 5 0.0026
150 FLAT AFFECT 6 0.0026
151 SUICIDAL IDEATION 234 0.0026
152 BLOOD PROLACTIN INCREASED 12 0.0025
153 CARDIOTOXICITY 22 0.0025
154 SINUS TACHYCARDIA 35 0.0025
155 COMPLETED SUICIDE 205 0.0025
156 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
157 IMPAIRED SELF-CARE 5 0.0024
158 PERSECUTORY DELUSION 6 0.0024
159 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18 0.0024
160 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
161 TOXIC ENCEPHALOPATHY 12 0.0024
162 TACHYPHRENIA 8 0.0023
163 GENERALISED TONIC-CLONIC SEIZURE 38 0.0023
164 DIABETIC FOOT 7 0.0023
165 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
166 RED BLOOD CELL SEDIMENTATION RATE INCREASED 25 0.0023
167 HAEMODYNAMIC INSTABILITY 17 0.0022
168 ADRENAL INSUFFICIENCY 27 0.0022
169 BIPOLAR DISORDER 24 0.0022
170 EXPOSURE TO TOXIC AGENT 7 0.0022
171 VENTRICULAR FIBRILLATION 24 0.0022
172 SELF-INJURIOUS IDEATION 9 0.0021
173 FOETAL GROWTH RESTRICTION 13 0.0021
174 AKATHISIA 29 0.0021
175 SEDATION 55 0.0021
176 SPEECH DISORDER DEVELOPMENTAL 6 0.0021
177 HYPOVOLAEMIC SHOCK 10 0.0021
178 BLOOD PRESSURE FLUCTUATION 50 0.0021
179 COORDINATION ABNORMAL 29 0.0021
180 MAJOR DEPRESSION 15 0.0021
181 RESPIRATORY ACIDOSIS 8 0.0020
182 LEFT VENTRICULAR FAILURE 7 0.0020
183 PSYCHIATRIC SYMPTOM 15 0.0020
184 BLOOD UREA INCREASED 34 0.0020
185 LOSS OF EMPLOYMENT 6 0.0020
186 INTENTIONAL SELF-INJURY 40 0.0020
187 DISSEMINATED TUBERCULOSIS 5 0.0019
188 PARKINSONISM 19 0.0019
189 FACIAL BONES FRACTURE 7 0.0019
190 END STAGE RENAL DISEASE 35 0.0019
191 INTENTIONAL OVERDOSE 123 0.0019
192 TARDIVE DYSKINESIA 54 0.0019
193 PERSONALITY DISORDER 5 0.0019
194 CHRONIC KIDNEY DISEASE 145 0.0019
195 HALLUCINATIONS, MIXED 8 0.0019
196 SLEEP TERROR 8 0.0019
197 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
198 CARDIO-RESPIRATORY ARREST 78 0.0019
199 HYPERPROLACTINAEMIA 12 0.0018
200 HALLUCINATION, AUDITORY 29 0.0018
201 LIGAMENT RUPTURE 8 0.0018
202 DRUG SCREEN FALSE POSITIVE 5 0.0018
203 ANAL HAEMORRHAGE 5 0.0018
204 ECONOMIC PROBLEM 27 0.0018
205 BLOOD TEST ABNORMAL 25 0.0018
206 CIRCULATORY COLLAPSE 30 0.0018
207 ULCER 28 0.0018
208 IMMUNE THROMBOCYTOPENIA 8 0.0017
209 OBSESSIVE-COMPULSIVE DISORDER 14 0.0017
210 BLOOD CREATININE ABNORMAL 6 0.0017
211 APLASTIC ANAEMIA 9 0.0017
212 METABOLIC ACIDOSIS 55 0.0017
213 FEELING OF DESPAIR 8 0.0017
214 MYDRIASIS 22 0.0017
215 PERIPHERAL ISCHAEMIA 7 0.0017
216 PRE-ECLAMPSIA 8 0.0017
217 PRODUCT SUPPLY ISSUE 12 0.0017
218 SLEEP APNOEA SYNDROME 32 0.0017
219 ANAL INCONTINENCE 15 0.0017
220 VITAMIN D DECREASED 14 0.0016
221 DUODENITIS 5 0.0016
222 SMALL FOR DATES BABY 8 0.0016
223 NEUROLEPTIC MALIGNANT SYNDROME 19 0.0016
224 SUBSTANCE ABUSE 13 0.0016
225 PREMATURE LABOUR 9 0.0016
226 AUTOIMMUNE THYROIDITIS 6 0.0016
227 MYOCARDITIS 18 0.0016
228 PANIC DISORDER 6 0.0015
229 INCOHERENT 10 0.0015
230 INJECTION SITE INDURATION 20 0.0015
231 DEPRESSED LEVEL OF CONSCIOUSNESS 61 0.0015
232 VENTRICULAR EXTRASYSTOLES 16 0.0015
233 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
234 PROSTATOMEGALY 6 0.0015
235 AFFECTIVE DISORDER 12 0.0015
236 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
237 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
238 INJECTION SITE INFECTION 5 0.0015
239 DEAFNESS NEUROSENSORY 5 0.0015
240 DRUG INTERACTION 239 0.0015
241 SUICIDE ATTEMPT 91 0.0015
242 NEPHROPATHY 14 0.0015
243 OLIGOHYDRAMNIOS 5 0.0015
244 ANHEDONIA 39 0.0015
245 FEELING DRUNK 11 0.0015
246 PARANOIA 25 0.0014
247 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
248 CERVICAL VERTEBRAL FRACTURE 5 0.0014
249 TROPONIN INCREASED 11 0.0014
250 GRANULOMA 5 0.0014
251 PREMATURE DELIVERY 23 0.0014
252 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
253 RESTLESS LEGS SYNDROME 26 0.0014
254 HANGOVER 5 0.0014
255 DEPRESSIVE SYMPTOM 5 0.0014
256 TONGUE DISCOMFORT 6 0.0014
257 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
258 SCREAMING 9 0.0014
259 VENTRICULAR TACHYCARDIA 23 0.0014
260 HYPOMANIA 5 0.0014
261 DENTAL CARIES 15 0.0014
262 CEREBRAL DISORDER 10 0.0014
263 CATATONIA 7 0.0013
264 IMPULSIVE BEHAVIOUR 5 0.0013
265 BLOOD CREATININE INCREASED 87 0.0013
266 BLOOD LACTIC ACID INCREASED 7 0.0013
267 TOXICITY TO VARIOUS AGENTS 224 0.0013
268 IMPAIRED DRIVING ABILITY 15 0.0013
269 FACE INJURY 5 0.0013
270 SCHIZOPHRENIA 16 0.0013
271 INSURANCE ISSUE 20 0.0013
272 DROOLING 9 0.0013
273 PROTEINURIA 24 0.0013
274 PANIC ATTACK 46 0.0013
275 ACUTE RESPIRATORY DISTRESS SYNDROME 22 0.0012
276 ENURESIS 5 0.0012
277 LACTIC ACIDOSIS 40 0.0012
278 HALLUCINATION, VISUAL 26 0.0012
279 HYPERTONIA 7 0.0012
280 ACUTE MYOCARDIAL INFARCTION 36 0.0012
281 WITHDRAWAL SYNDROME 51 0.0012
282 FOOT OPERATION 6 0.0012
283 ILEUS 15 0.0012
284 ORTHOSTATIC HYPOTENSION 21 0.0012
285 PROTEIN URINE PRESENT 6 0.0012
286 MENTAL DISORDER 52 0.0012
287 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
288 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
289 BRAIN OEDEMA 15 0.0012
290 DYSPHORIA 6 0.0012
291 BLOOD TESTOSTERONE DECREASED 8 0.0012
292 APATHY 17 0.0012
293 BLOOD PRESSURE INADEQUATELY CONTROLLED 7 0.0012
294 UNRESPONSIVE TO STIMULI 30 0.0012
295 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
296 MANIA 19 0.0012
297 STATUS EPILEPTICUS 13 0.0011
298 FORMICATION 8 0.0011
299 RESTLESSNESS 42 0.0011
300 SPINAL OSTEOARTHRITIS 10 0.0011
301 BRADYCARDIA 60 0.0011
302 PREMATURE BABY 34 0.0011
303 THERMAL BURN 8 0.0011
304 WRONG DRUG ADMINISTERED 10 0.0011
305 PSYCHOTIC DISORDER 33 0.0011
306 HYPOTENSION 224 0.0011
307 SPLENOMEGALY 13 0.0011
308 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
309 SYNCOPE 111 0.0011
310 HIP SURGERY 6 0.0011
311 SKIN LACERATION 12 0.0011
312 DEPRESSION 251 0.0011
313 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
314 HYDROCEPHALUS 6 0.0011
315 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31 0.0011
316 DELUSION 17 0.0011
317 EJECTION FRACTION DECREASED 17 0.0011
318 DISEASE COMPLICATION 5 0.0011
319 ACUTE KIDNEY INJURY 167 0.0011
320 SLEEP DISORDER 77 0.0011
321 PROSTATIC DISORDER 6 0.0011
322 HYPERKERATOSIS 6 0.0011
323 MUSCLE RIGIDITY 13 0.0011
324 HYPERKALAEMIA 38 0.0011
325 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
326 EUPHORIC MOOD 11 0.0011
327 PERFORMANCE STATUS DECREASED 5 0.0011
328 FOOT FRACTURE 20 0.0011
329 CARDIAC TAMPONADE 5 0.0011
330 ABNORMAL DREAMS 29 0.0010
331 SEIZURE 121 0.0010
332 LIPASE INCREASED 8 0.0010
333 DEPRESSED MOOD 55 0.0010
334 TYPE 2 DIABETES MELLITUS 35 0.0010
335 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
336 HUMERUS FRACTURE 5 0.0010
337 FOOD ALLERGY 8 0.0010
338 HYPERVENTILATION 6 0.0010
339 ENTEROCOCCAL INFECTION 5 0.0010
340 CONCUSSION 8 0.0010
341 RHABDOMYOLYSIS 43 0.0010
342 THROMBOTIC MICROANGIOPATHY 10 0.0010
343 KIDNEY INFECTION 20 0.0010
344 DECREASED INTEREST 6 0.0010
345 DRUG SCREEN POSITIVE 8 0.0010
346 HYPERVOLAEMIA 5 0.0010
347 SINUS HEADACHE 6 0.0010
348 IMMUNODEFICIENCY 15 0.0010
349 TOOTH FRACTURE 11 0.0010
350 NEEDLE ISSUE 29 0.0010
351 RENAL FAILURE 132 0.0010
352 HIDRADENITIS 9 0.0010
353 EATING DISORDER 21 0.0010
354 COGNITIVE DISORDER 46 0.0010
355 RED BLOOD CELL COUNT DECREASED 28 0.0010
356 RESPIRATORY DEPRESSION 12 0.0010
357 ANAPHYLACTIC REACTION 54 0.0010
358 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
359 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
360 FLANK PAIN 9 0.0010
361 ANXIETY 272 0.0010
362 BLOOD PRESSURE ABNORMAL 19 0.0010
363 MOUTH HAEMORRHAGE 7 0.0010
364 MUSCLE TWITCHING 22 0.0010
365 THIRST 17 0.0010
366 FOOD CRAVING 5 0.0009
367 ANGER 32 0.0009
368 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
369 HEMIPARESIS 16 0.0009
370 OBESITY 15 0.0009
371 AFFECT LABILITY 9 0.0009
372 GALACTORRHOEA 6 0.0009
373 ANAL FISSURE 5 0.0009
374 DYSTONIA 18 0.0009
375 OXYGEN SATURATION DECREASED 52 0.0009
376 MYOCLONUS 11 0.0009
377 RENAL TUBULAR NECROSIS 9 0.0009
378 ACIDOSIS 7 0.0009
379 THERAPY CHANGE 9 0.0009
380 ORAL CANDIDIASIS 12 0.0009
381 MIDDLE INSOMNIA 17 0.0009
382 RENAL INJURY 27 0.0009
383 BLADDER DISORDER 9 0.0009
384 APPETITE DISORDER 6 0.0009
385 MIGRAINE 86 0.0009
386 TACHYCARDIA 80 0.0009
387 MALNUTRITION 10 0.0009
388 HEAVY MENSTRUAL BLEEDING 8 0.0009
389 HYPOTHERMIA 9 0.0009
390 POSTOPERATIVE WOUND INFECTION 6 0.0009
391 HEAD INJURY 28 0.0009
392 DRUG LEVEL DECREASED 9 0.0009
393 TRICUSPID VALVE INCOMPETENCE 7 0.0009
394 INFUSION RELATED REACTION 58 0.0009
395 HYPERSOMNIA 25 0.0009
396 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
397 FRUSTRATION TOLERANCE DECREASED 7 0.0009
398 LARGE INTESTINE POLYP 6 0.0009
399 CARDIAC ARREST 71 0.0009
400 DISABILITY 17 0.0009
401 AGGRESSION 43 0.0009
402 THINKING ABNORMAL 16 0.0009
403 UPPER LIMB FRACTURE 17 0.0009
404 SEXUAL DYSFUNCTION 10 0.0009
405 JOINT DISLOCATION 9 0.0009
406 COLD SWEAT 15 0.0009
407 RENAL PAIN 9 0.0008
408 AGITATION 62 0.0008
409 URINARY INCONTINENCE 25 0.0008
410 ANKLE FRACTURE 13 0.0008
411 DELIRIUM 29 0.0008
412 AMNESIA 54 0.0008
413 RIB FRACTURE 17 0.0008
414 THROAT IRRITATION 37 0.0008
415 TOOTH LOSS 17 0.0008
416 PHARYNGEAL SWELLING 8 0.0008
417 NASAL CONGESTION 48 0.0008
418 HEPATOMEGALY 8 0.0008
419 BRONCHITIS 60 0.0008
420 MYOPATHY 7 0.0008
421 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
422 PULMONARY MASS 12 0.0008
423 OCULAR DISCOMFORT 9 0.0008
424 HYPERHIDROSIS 103 0.0008
425 IRRITABLE BOWEL SYNDROME 17 0.0008
426 OSTEOPENIA 12 0.0008
427 HAEMATURIA 27 0.0008
428 DRY THROAT 8 0.0008
429 MOOD SWINGS 25 0.0008
430 IRRITABILITY 47 0.0008
431 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
432 ANAPHYLACTIC SHOCK 20 0.0008
433 RENAL IMPAIRMENT 65 0.0008
434 LIMB INJURY 21 0.0008
435 CRYING 28 0.0008
436 C-REACTIVE PROTEIN INCREASED 28 0.0008
437 BRAIN FOG 12 0.0008
438 BRADYPHRENIA 5 0.0008
439 MULTIPLE ALLERGIES 6 0.0008
440 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
441 DRUG WITHDRAWAL SYNDROME 67 0.0008
442 LOSS OF CONSCIOUSNESS 97 0.0008
443 HYPERTENSION 159 0.0007
444 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
445 URINARY RETENTION 25 0.0007
446 SENSORY LOSS 6 0.0007
447 MYASTHENIA GRAVIS 6 0.0007
448 BLOOD SODIUM DECREASED 14 0.0007
449 NEUROTOXICITY 13 0.0007
450 THROAT TIGHTNESS 20 0.0007
451 SHOCK 17 0.0007
452 BACK INJURY 8 0.0007
453 ENCEPHALOPATHY 18 0.0007
454 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
455 HALLUCINATION 55 0.0007
456 TENDON RUPTURE 9 0.0007
457 DRY MOUTH 59 0.0007
458 GASTROINTESTINAL PAIN 8 0.0007
459 ONYCHOCLASIS 5 0.0007
460 JOINT EFFUSION 5 0.0007
461 DIVERTICULITIS 20 0.0007
462 MENTAL STATUS CHANGES 20 0.0007
463 HAEMORRHOIDS 14 0.0007
464 DYSKINESIA 29 0.0007
465 PANCREATITIS ACUTE 16 0.0007
466 TREMOR 118 0.0007
467 HEART RATE IRREGULAR 16 0.0007
468 HAND FRACTURE 5 0.0007
469 BALANCE DISORDER 61 0.0007
470 FACIAL PARALYSIS 6 0.0007
471 RESPIRATORY FAILURE 51 0.0007
472 CARDIAC OPERATION 6 0.0007
473 POOR QUALITY SLEEP 15 0.0007
474 HYSTERECTOMY 6 0.0007
475 PANIC REACTION 5 0.0007
476 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
477 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
478 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
479 BLOOD GLUCOSE DECREASED 33 0.0007
480 SYRINGE ISSUE 12 0.0007
481 SPINAL PAIN 8 0.0007
482 INITIAL INSOMNIA 7 0.0007
483 MUSCLE TIGHTNESS 11 0.0007
484 FALL 226 0.0007
485 BLINDNESS TRANSIENT 5 0.0007
486 THERAPEUTIC RESPONSE DECREASED 41 0.0007
487 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37 0.0007
488 CHOLECYSTITIS 8 0.0007
489 HYPERLIPIDAEMIA 8 0.0007
490 GASTROINTESTINAL INFECTION 6 0.0007
491 WRIST FRACTURE 8 0.0007
492 SOMNOLENCE 134 0.0007
493 BLOOD PRESSURE DECREASED 44 0.0007
494 DRY EYE 33 0.0007
495 PRODUCT AVAILABILITY ISSUE 15 0.0007
496 HYPERTHERMIA 5 0.0007
497 EPILEPSY 20 0.0007
498 RECTAL HAEMORRHAGE 28 0.0007
499 ALANINE AMINOTRANSFERASE INCREASED 40 0.0007
500 NERVE COMPRESSION 6 0.0006
501 SMALL INTESTINAL OBSTRUCTION 8 0.0006
502 EMOTIONAL DISORDER 20 0.0006
503 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
504 OROPHARYNGEAL PAIN 60 0.0006
505 GASTRITIS 17 0.0006
506 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
507 PHOTOPHOBIA 12 0.0006
508 SEASONAL ALLERGY 9 0.0006
509 DYSPHAGIA 60 0.0006
510 OSTEOPOROSIS 26 0.0006
511 BLOOD POTASSIUM DECREASED 19 0.0006
512 DISORIENTATION 25 0.0006
513 OVERDOSE 136 0.0006
514 BLOOD ALBUMIN DECREASED 5 0.0006
515 MULTIPLE SCLEROSIS 30 0.0006
516 HEART RATE DECREASED 22 0.0006
517 DYSURIA 23 0.0006
518 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
519 MENTAL IMPAIRMENT 15 0.0006
520 FLUID OVERLOAD 9 0.0006
521 FEELING ABNORMAL 148 0.0006
522 FIBROMYALGIA 15 0.0006
523 DYSSTASIA 18 0.0006
524 PROCEDURAL PAIN 17 0.0006
525 DYSARTHRIA 23 0.0006
526 NEPHROLITHIASIS 28 0.0006
527 INTESTINAL OBSTRUCTION 23 0.0006
528 RETCHING 13 0.0006
529 LETHARGY 35 0.0006
530 IMMUNE SYSTEM DISORDER 8 0.0006
531 TOOTH INFECTION 8 0.0006
532 BONE DENSITY DECREASED 19 0.0006
533 HAEMATOCRIT DECREASED 12 0.0006
534 ACUTE CORONARY SYNDROME 5 0.0006
535 DYSMENORRHOEA 8 0.0006
536 TREATMENT NONCOMPLIANCE 33 0.0006
537 HYPOTONIA 6 0.0006
538 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11 0.0006
539 POLLAKIURIA 25 0.0006
540 SURGERY 35 0.0006
541 HYPOXIA 21 0.0006
542 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
543 NECK PAIN 33 0.0006
544 OSTEOARTHRITIS 25 0.0006
545 MOTOR DYSFUNCTION 6 0.0006
546 SLUGGISHNESS 6 0.0006
547 DEVICE RELATED INFECTION 9 0.0006
548 RASH MACULO-PAPULAR 13 0.0006
549 THYROID DISORDER 9 0.0006
550 PERIPHERAL COLDNESS 8 0.0006
551 VOMITING 273 0.0006
552 RESPIRATORY ARREST 16 0.0006
553 RESPIRATORY DISTRESS 16 0.0006
554 URTICARIA 97 0.0006
555 INSOMNIA 154 0.0006
556 HYPERGLYCAEMIA 21 0.0006
557 RESPIRATORY TRACT INFECTION 15 0.0006
558 TENDERNESS 6 0.0006
559 APHONIA 8 0.0006
560 CONSTIPATION 125 0.0006
561 DECREASED APPETITE 133 0.0006
562 SPEECH DISORDER 30 0.0006
563 CARPAL TUNNEL SYNDROME 8 0.0006
564 CARDIOMEGALY 7 0.0006
565 INJECTION SITE MASS 21 0.0006
566 INCONTINENCE 6 0.0006
567 IMMUNOSUPPRESSION 5 0.0006
568 EXTRAPYRAMIDAL DISORDER 14 0.0006
569 ABDOMINAL PAIN UPPER 116 0.0006
570 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
571 DIZZINESS 280 0.0006
572 IMPAIRED WORK ABILITY 12 0.0006
573 INTENTIONAL DOSE OMISSION 16 0.0006
574 SENSORY DISTURBANCE 9 0.0006
575 BRONCHOSPASM 8 0.0006
576 SECRETION DISCHARGE 7 0.0006
577 RENAL DISORDER 26 0.0006
578 BLOOD CHOLESTEROL INCREASED 26 0.0006
579 PARAESTHESIA ORAL 8 0.0006
580 HAEMATEMESIS 14 0.0006
581 INJECTION SITE REACTION 38 0.0006
582 PALLOR 15 0.0006
583 CONFUSIONAL STATE 89 0.0006
584 MOOD ALTERED 15 0.0005
585 MUSCULAR WEAKNESS 62 0.0005
586 INFUSION SITE PAIN 7 0.0005
587 BLOOD PRESSURE INCREASED 83 0.0005
588 FEEDING DISORDER 11 0.0005
589 PERICARDITIS 9 0.0005
590 DIARRHOEA HAEMORRHAGIC 5 0.0005
591 NEURALGIA 13 0.0005
592 MUSCULOSKELETAL PAIN 28 0.0005
593 CANDIDA INFECTION 9 0.0005
594 ABNORMAL BEHAVIOUR 21 0.0005
595 BLOOD URINE PRESENT 10 0.0005
596 INTENTIONAL PRODUCT USE ISSUE 46 0.0005
597 VERTIGO 32 0.0005
598 ANGINA PECTORIS 15 0.0005
599 INCREASED APPETITE 10 0.0005
600 QUALITY OF LIFE DECREASED 7 0.0005
601 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
602 BACK PAIN 121 0.0005
603 FEAR 14 0.0005
604 CONDITION AGGRAVATED 158 0.0005
605 ATELECTASIS 5 0.0005
606 ELECTROLYTE IMBALANCE 6 0.0005
607 DIZZINESS POSTURAL 5 0.0005
608 NEUROPATHY PERIPHERAL 49 0.0005
609 VASCULITIS 6 0.0005
610 TACHYPNOEA 7 0.0005
611 HEART RATE INCREASED 51 0.0005
612 AUTOIMMUNE DISORDER 5 0.0005
613 CHEST PAIN 95 0.0005
614 THERAPEUTIC RESPONSE SHORTENED 17 0.0005
615 SKIN LESION 14 0.0005
616 HEPATIC FUNCTION ABNORMAL 19 0.0005
617 HEAD DISCOMFORT 9 0.0005
618 DRUG RESISTANCE 13 0.0005
619 LIGAMENT SPRAIN 5 0.0005
620 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
621 FOETAL EXPOSURE DURING PREGNANCY 41 0.0005
622 PALPITATIONS 59 0.0005
623 INABILITY TO AFFORD MEDICATION 5 0.0005
624 ROAD TRAFFIC ACCIDENT 21 0.0005
625 HAEMATOMA 13 0.0005
626 NAUSEA 397 0.0005
627 GOUT 9 0.0005
628 DISTURBANCE IN ATTENTION 27 0.0005
629 TINNITUS 23 0.0005
630 OVARIAN CYST 5 0.0005
631 DIABETIC KETOACIDOSIS 12 0.0005
632 EXPOSURE DURING PREGNANCY 31 0.0005
633 HEPATIC FAILURE 15 0.0005
634 NIGHT SWEATS 16 0.0005
635 WEIGHT INCREASED 111 0.0005
636 PELVIC PAIN 9 0.0005
637 MEMORY IMPAIRMENT 68 0.0005
638 NOCTURIA 6 0.0005
639 SEPSIS 55 0.0005
640 BACK DISORDER 8 0.0005
641 PULMONARY OEDEMA 22 0.0005
642 WEIGHT DECREASED 136 0.0005
643 MULTIPLE FRACTURES 8 0.0005
644 PRODUCT SUBSTITUTION ISSUE 28 0.0005
645 CYST 6 0.0005
646 POOR VENOUS ACCESS 5 0.0005
647 PERITONITIS 10 0.0005
648 BACTERIAL INFECTION 9 0.0005
649 HAIR COLOUR CHANGES 6 0.0005
650 LIP SWELLING 16 0.0005
651 SWOLLEN TONGUE 15 0.0005
652 FUNGAL INFECTION 16 0.0005
653 POISONING 6 0.0005
654 ANGIOEDEMA 21 0.0005
655 MUSCLE SPASMS 87 0.0005
656 CARDIOMYOPATHY 7 0.0005
657 GASTRIC ULCER 9 0.0005
658 MUSCULOSKELETAL DISORDER 9 0.0005
659 DIABETES MELLITUS 36 0.0005
660 ACUTE RESPIRATORY FAILURE 9 0.0005
661 THERAPY CESSATION 24 0.0005
662 FEELING COLD 13 0.0005
663 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
664 PRESCRIBED OVERDOSE 9 0.0005
665 ACCIDENTAL OVERDOSE 17 0.0005
666 EAR PAIN 9 0.0005
667 COMA 22 0.0005
668 OEDEMA 25 0.0005
669 OFF LABEL USE 402 0.0005
670 PRODUCT PRESCRIBING ISSUE 10 0.0005
671 DISCOMFORT 28 0.0005
672 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
673 RHEUMATOID ARTHRITIS 52 0.0005
674 OESOPHAGITIS 5 0.0005
675 DRUG ABUSE 38 0.0005
676 AMENORRHOEA 8 0.0005
677 STAPHYLOCOCCAL INFECTION 15 0.0005
678 VIRAL INFECTION 15 0.0005
679 HOSPITALISATION 69 0.0004
680 HEADACHE 281 0.0004
681 THERAPY INTERRUPTED 32 0.0004
682 TREATMENT FAILURE 37 0.0004
683 PRODUCT PHYSICAL ISSUE 9 0.0004
684 PRODUCT ADMINISTRATION ERROR 9 0.0004
685 CYANOSIS 7 0.0004
686 BLOOD CALCIUM DECREASED 5 0.0004
687 PRODUCT USE IN UNAPPROVED INDICATION 110 0.0004
688 PRODUCT TASTE ABNORMAL 6 0.0004
689 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
690 COMPLICATION OF DEVICE REMOVAL 8 0.0004
691 LEUKOCYTOSIS 8 0.0004
692 ABDOMINAL PAIN 102 0.0004
693 INJECTION SITE WARMTH 9 0.0004
694 CORONARY ARTERY OCCLUSION 6 0.0004
695 CELLULITIS 22 0.0004
696 DEHYDRATION 58 0.0004
697 HYPOAESTHESIA 65 0.0004
698 PERICARDIAL EFFUSION 10 0.0004
699 ARTHROPATHY 24 0.0004
700 CONJUNCTIVITIS 8 0.0004
701 ABDOMINAL DISTENSION 45 0.0004
702 AGRANULOCYTOSIS 8 0.0004
703 INFLUENZA 48 0.0004
704 HEPATITIS 11 0.0004
705 PAIN 263 0.0004
706 URINARY TRACT INFECTION 73 0.0004
707 MOUTH ULCERATION 9 0.0004
708 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 76 0.0004
709 COAGULOPATHY 7 0.0004
710 IMPAIRED QUALITY OF LIFE 6 0.0004
711 NERVOUS SYSTEM DISORDER 13 0.0004
712 COVID-19 73 0.0004
713 GLAUCOMA 8 0.0004
714 SWELLING FACE 27 0.0004
715 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
716 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
717 FLUID RETENTION 21 0.0004
718 GASTROENTERITIS 6 0.0004
719 SINUSITIS 42 0.0004
720 PERIPHERAL SWELLING 63 0.0004
721 CYSTITIS 13 0.0004
722 LIVER INJURY 10 0.0004
723 CONTUSION 39 0.0004
724 MOVEMENT DISORDER 13 0.0004
725 SKIN HAEMORRHAGE 6 0.0004
726 TOOTH DISORDER 9 0.0004
727 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
728 CATARACT 24 0.0004
729 DYSPNOEA 227 0.0004
730 THERAPY NON-RESPONDER 18 0.0004
731 HAEMATOCHEZIA 22 0.0004
732 HYPOAESTHESIA ORAL 6 0.0004
733 UNEVALUABLE EVENT 30 0.0004
734 EMOTIONAL DISTRESS 48 0.0004
735 CORONARY ARTERY DISEASE 12 0.0004
736 HYPOPHAGIA 10 0.0004
737 COUGH 109 0.0004
738 ILLNESS 40 0.0004
739 MUSCULOSKELETAL STIFFNESS 34 0.0004
740 TENDONITIS 6 0.0004
741 DIARRHOEA 250 0.0004
742 OSTEOMYELITIS 7 0.0004
743 HIATUS HERNIA 5 0.0004
744 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
745 DIPLOPIA 10 0.0004
746 PRODUCT DOSE OMISSION ISSUE 113 0.0004
747 NERVOUSNESS 20 0.0004
748 CHEST DISCOMFORT 39 0.0004
749 ANKYLOSING SPONDYLITIS 5 0.0004
750 PANCREATITIS 20 0.0004
751 RESPIRATORY TRACT CONGESTION 6 0.0004
752 OEDEMA PERIPHERAL 46 0.0004
753 ABSCESS 6 0.0004
754 CARDIAC FAILURE 30 0.0004
755 GAIT DISTURBANCE 71 0.0004
756 PSORIATIC ARTHROPATHY 15 0.0004
757 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
758 FAECES DISCOLOURED 8 0.0004
759 BLINDNESS 15 0.0004
760 RESPIRATORY DISORDER 11 0.0004
761 DYSPEPSIA 36 0.0004
762 POST PROCEDURAL COMPLICATION 7 0.0004
763 PNEUMONIA 118 0.0004
764 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
765 CYTOMEGALOVIRUS INFECTION 6 0.0004
766 AGEUSIA 9 0.0004
767 HUNGER 5 0.0004
768 CHILLS 42 0.0004
769 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
770 ANAEMIA 68 0.0004
771 FATIGUE 277 0.0004
772 CARDIOVASCULAR DISORDER 9 0.0004
773 ARTHRALGIA 147 0.0004
774 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
775 METRORRHAGIA 6 0.0004
776 COMPLICATION OF DEVICE INSERTION 7 0.0004
777 SPINAL FRACTURE 7 0.0003
778 NASOPHARYNGITIS 64 0.0003
779 MYALGIA 59 0.0003
780 MYELODYSPLASTIC SYNDROME 5 0.0003
781 DEVICE BREAKAGE 14 0.0003
782 SEPTIC SHOCK 15 0.0003
783 HYPOKINESIA 5 0.0003
784 BODY TEMPERATURE INCREASED 7 0.0003
785 FEELING HOT 21 0.0003
786 RHINORRHOEA 22 0.0003
787 LYMPHOCYTE COUNT DECREASED 6 0.0003
788 BLISTER 19 0.0003
789 EAR INFECTION 9 0.0003
790 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
791 RASH ERYTHEMATOUS 16 0.0003
792 HAEMORRHAGE INTRACRANIAL 5 0.0003
793 MOBILITY DECREASED 24 0.0003
794 TOOTHACHE 6 0.0003
795 SWELLING 31 0.0003
796 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
797 BONE DISORDER 6 0.0003
798 PHARYNGEAL OEDEMA 5 0.0003
799 VISUAL IMPAIRMENT 40 0.0003
800 HAEMOPTYSIS 9 0.0003
801 DEMENTIA 9 0.0003
802 VISION BLURRED 44 0.0003
803 ASTHENIA 120 0.0003
804 HOT FLUSH 24 0.0003
805 MELAENA 7 0.0003
806 ARTHRITIS 25 0.0003
807 FLATULENCE 18 0.0003
808 FRACTURE 6 0.0003
809 ARRHYTHMIA 15 0.0003
810 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
811 PNEUMOTHORAX 5 0.0003
812 FEELING JITTERY 6 0.0003
813 MALAISE 138 0.0003
814 DRUG INEFFECTIVE 414 0.0003
815 HYPOTHYROIDISM 10 0.0003
816 PULMONARY FIBROSIS 6 0.0003
817 ORAL PAIN 7 0.0003
818 PAIN IN EXTREMITY 92 0.0003
819 LYMPHADENOPATHY 11 0.0003
820 HERNIA 6 0.0003
821 INFLAMMATION 16 0.0003
822 SKIN ULCER 8 0.0003
823 HYPOGLYCAEMIA 15 0.0003
824 PRODUCT USE ISSUE 58 0.0003
825 CHOKING 6 0.0003
826 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 62 0.0003
827 PARAESTHESIA 48 0.0003
828 IMPAIRED HEALING 10 0.0003
829 HYPOKALAEMIA 14 0.0003
830 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
831 HYPERSENSITIVITY 56 0.0003
832 MENSTRUATION IRREGULAR 8 0.0003
833 ABDOMINAL DISCOMFORT 50 0.0003
834 DYSGEUSIA 22 0.0003
835 PLEURAL EFFUSION 18 0.0003
836 PNEUMONITIS 8 0.0003
837 LIVER DISORDER 13 0.0003
838 PRODUCT DOSE OMISSION 19 0.0003
839 LIMB DISCOMFORT 9 0.0003
840 MUSCULOSKELETAL DISCOMFORT 5 0.0003
841 DRUG INTOLERANCE 28 0.0003
842 LOCALISED INFECTION 7 0.0003
843 PRESYNCOPE 7 0.0003
844 UNDERDOSE 21 0.0003
845 WOUND 8 0.0003
846 INTENTIONAL PRODUCT MISUSE 25 0.0003
847 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
848 PLATELET COUNT DECREASED 30 0.0003
849 LEUKOPENIA 14 0.0003
850 INFLUENZA LIKE ILLNESS 23 0.0003
851 DRUG EFFECT DECREASED 15 0.0003
852 CARDIAC DISORDER 26 0.0003
853 PYREXIA 96 0.0003
854 DEEP VEIN THROMBOSIS 18 0.0003
855 ABDOMINAL PAIN LOWER 7 0.0003
856 RASH PRURITIC 15 0.0003
857 ASTHMA 31 0.0003
858 INJECTION SITE SWELLING 21 0.0003
859 BONE PAIN 16 0.0003
860 GAIT INABILITY 9 0.0003
861 HEPATIC STEATOSIS 5 0.0003
862 THROMBOCYTOPENIA 30 0.0003
863 DEAFNESS 7 0.0003
864 RASH PAPULAR 6 0.0003
865 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
866 JOINT STIFFNESS 7 0.0003
867 CHROMATURIA 6 0.0003
868 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
869 HAEMOGLOBIN DECREASED 27 0.0003
870 DRUG DEPENDENCE 42 0.0003
871 CHOLESTASIS 5 0.0003
872 LOWER LIMB FRACTURE 5 0.0003
873 JAUNDICE 7 0.0003
874 DRUG DOSE OMISSION 43 0.0003
875 PAIN OF SKIN 7 0.0003
876 ERUCTATION 5 0.0003
877 GASTROINTESTINAL DISORDER 23 0.0003
878 ATRIAL FIBRILLATION 25 0.0003
879 ORAL HERPES 5 0.0003
880 ADVERSE DRUG REACTION 23 0.0003
881 INJURY 18 0.0003
882 PRODUCTIVE COUGH 12 0.0003
883 CARDIAC FAILURE CONGESTIVE 20 0.0002
884 HIP FRACTURE 8 0.0002
885 INJECTION SITE PAIN 76 0.0002
886 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
887 CHOLELITHIASIS 8 0.0002
888 ABASIA 6 0.0002
889 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
890 EYE SWELLING 9 0.0002
891 LIVER FUNCTION TEST ABNORMAL 7 0.0002
892 SKIN DISORDER 8 0.0002
893 SKIN DISCOLOURATION 11 0.0002
894 DYSPNOEA EXERTIONAL 9 0.0002
895 ASCITES 7 0.0002
896 COLITIS 9 0.0002
897 RENAL FAILURE ACUTE 10 0.0002
898 NEUTROPENIA 32 0.0002
899 INFECTION 34 0.0002
900 JOINT INJURY 5 0.0002
901 LIVER FUNCTION TEST INCREASED 5 0.0002
902 HYPOACUSIS 10 0.0002
903 PULMONARY EMBOLISM 22 0.0002
904 PSORIASIS 30 0.0002
905 PRODUCT QUALITY ISSUE 31 0.0002
906 DRUG ADMINISTRATION ERROR 7 0.0002
907 ADVERSE EVENT 21 0.0002
908 RASH 98 0.0002
909 ABORTION SPONTANEOUS 9 0.0002
910 CEREBRAL HAEMORRHAGE 8 0.0002
911 BLOOD GLUCOSE INCREASED 42 0.0002
912 BLOOD BILIRUBIN INCREASED 6 0.0002
913 HEPATIC ENZYME INCREASED 15 0.0002
914 MEDICATION ERROR 12 0.0002
915 HYPONATRAEMIA 12 0.0002
916 MYOCARDIAL INFARCTION 37 0.0002
917 PAIN IN JAW 6 0.0002
918 EXPIRED PRODUCT ADMINISTERED 7 0.0002
919 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
920 VAGINAL HAEMORRHAGE 9 0.0002
921 PRURITUS 79 0.0002
922 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
923 DISEASE PROGRESSION 24 0.0002
924 WHEEZING 12 0.0002
925 INCORRECT DOSE ADMINISTERED 46 0.0002
926 COLITIS ULCERATIVE 9 0.0002
927 PNEUMONIA ASPIRATION 5 0.0002
928 THROMBOSIS 16 0.0002
929 APHASIA 6 0.0002
930 EXTRA DOSE ADMINISTERED 8 0.0002
931 PANCYTOPENIA 11 0.0002
932 FLUSHING 20 0.0002
933 PRODUCT ADHESION ISSUE 7 0.0002
934 INJECTION SITE RASH 6 0.0002
935 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
936 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
937 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
938 APPLICATION SITE ERYTHEMA 5 0.0002
939 DERMATITIS ATOPIC 10 0.0002
940 FREQUENT BOWEL MOVEMENTS 5 0.0002
941 DEVICE EXPULSION 12 0.0002
942 VISUAL ACUITY REDUCED 6 0.0002
943 GASTRIC DISORDER 6 0.0002
944 JOINT SWELLING 21 0.0002
945 EPISTAXIS 13 0.0002
946 ALOPECIA 34 0.0002
947 NEUTROPHIL COUNT DECREASED 7 0.0002
948 CEREBROVASCULAR ACCIDENT 29 0.0002
949 BURNING SENSATION 12 0.0002
950 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
951 LABORATORY TEST ABNORMAL 5 0.0002
952 DISEASE RECURRENCE 8 0.0002
953 DEVICE ISSUE 15 0.0002
954 LACRIMATION INCREASED 5 0.0002
955 DRUG EFFECT INCOMPLETE 6 0.0002
956 STOMATITIS 10 0.0002
957 GYNAECOMASTIA 5 0.0002
958 FEMUR FRACTURE 5 0.0002
959 INJECTION SITE ERYTHEMA 20 0.0002
960 EYE PAIN 9 0.0002
961 DRUG-INDUCED LIVER INJURY 5 0.0002
962 DEVICE MALFUNCTION 11 0.0002
963 SKIN EXFOLIATION 13 0.0002
964 SKIN BURNING SENSATION 11 0.0002
965 OSTEONECROSIS 5 0.0002
966 EYE DISORDER 5 0.0002
967 INJECTION SITE PRURITUS 10 0.0001
968 HERPES ZOSTER 8 0.0001
969 INJECTION SITE HAEMORRHAGE 11 0.0001
970 DYSPHONIA 8 0.0001
971 FEBRILE NEUTROPENIA 9 0.0001
972 DEATH 116 0.0001
973 ILL-DEFINED DISORDER 8 0.0001
974 ERYTHEMA 27 0.0001
975 SKIN IRRITATION 6 0.0001
976 PLASMA CELL MYELOMA 5 0.0001
977 OCULAR HYPERAEMIA 6 0.0001
978 NO ADVERSE EVENT 21 0.0001
979 DEVICE LEAKAGE 5 0.0001
980 INJECTION SITE BRUISING 9 0.0001
981 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
982 ACNE 8 0.0001
983 CONVULSION 6 0.0001
984 EYE IRRITATION 6 0.0001
985 LUNG DISORDER 5 0.0001
986 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
987 DRUG DOSE OMISSION BY DEVICE 6 0.0001
988 DRY SKIN 10 0.0001
989 PRODUCT STORAGE ERROR 6 0.0001
990 HAEMORRHAGE 7 0.0001